electroCore, Inc. (ECOR) vs Humacyte, Inc. (HUMA)
A side-by-side comparison of electroCore, Inc. and Humacyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ECOR
electroCore, Inc.
$9.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HUMA
Humacyte, Inc.
$0.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ECOR vs HUMA
growth of $100 · dividends reinvested · last 6yECOR -57.5% (-13.3%/yr)HUMA -94.8% (-39.0%/yr)ECOR compounded faster over this window
Log scale — wide-divergence pair
ECOR HUMA
ECOR vs HUMA: by the numbers
- •ECOR is the larger company ($89M vs $80M market cap).
- •Both run net losses; ECOR's is the smaller (-39.96% vs -4560.82% net margin).
- •ECOR grew revenue faster over the past five years (52.51% vs 2.41% CAGR).
Metrics side by side
Valuation
| Metric | ECOR | HUMA |
|---|---|---|
| P/S ratio | 2.42 | 37.86 |
| P/B ratio | N/A | 2.57 |
Profitability
| Metric | ECOR | HUMA |
|---|---|---|
| Gross margin | 87.06% | -736.46% |
| Operating margin | -37.64% | -5271.69% |
| Net margin | -39.96% | -4560.82% |
| ROE | N/A | -309.44% |
| ROIC | -217.73% | -90.27% |
Growth (annualized)
| Metric | ECOR | HUMA |
|---|---|---|
| Revenue CAGR (5Y) | 52.51% | 2.41% |
| Total return CAGR (5Y) | -8.10% | -45.73% |
Frequently asked
- Which has grown faster, ECOR or HUMA?
- Over the past five years, ECOR grew revenue faster — ECOR at a 52.51% CAGR versus HUMA at 2.41%.
- How have ECOR and HUMA total returns compared?
- Over the past 5 years, ECOR delivered -8.10% and HUMA delivered -45.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
electroCore ROEHumacyte ROEelectroCore operating marginHumacyte operating marginelectroCore revenue growthHumacyte revenue growthelectroCore free cash flowHumacyte free cash flow
electroCore & Humacyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.